Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature

Intravenous immunoglobulins (IVIg) were first introduced in the middle of the twentieth century for the treatment of primary immunodeficiencies. In 1981, Paul Imbach noticed an improvement of immune-mediated thrombocytopenia, in patients receiving IVIg for immunodeficiencies. This opened a new era f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kivity, Shaye, Katz, Uriel, Daniel, Natalie, Nussinovitch, Udi, Papageorgiou, Neophytos, Shoenfeld, Yehuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Humana Press Inc 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101816/
https://www.ncbi.nlm.nih.gov/pubmed/19590986
http://dx.doi.org/10.1007/s12016-009-8155-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101816/
https://www.ncbi.nlm.nih.gov/pubmed/19590986
http://dx.doi.org/10.1007/s12016-009-8155-9

Ejemplares similares